IP Library › Patent Application 11417216
Patent Application
App. No. 11/417,216

Receptor ligands and methods of modulating receptors

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/417,216
Abstract

The invention provides natural ligands of various receptors and methods of identifying modulators of various receptors using the ligands. Methods of using the modulators to treat diseases or disorder associated with dysfunction of the receptor are also provided.

Claims (18)

1 . A method of identifying a modulator of a TGR18 polypeptide that has G-protein coupled receptor activity and (A) comprises at least 70% amino acid sequence identity to SEQ ID NO:16 (B) consists of at least 50 contiguous amino acids of SEQ ID NO:16, or (C) comprises the amino acid sequence of SEQ ID NO:16; wherein the method comprises:

contacting the polypeptide with: a candidate modulator compound and succinic acid; and

determining the level of activity of the polypeptide in comparison to the level of activity of the polypeptide in the absence of succinic acid.

2 . The method of claim 1 , wherein the step of determining the level of activity comprises a competitive assay.

3 . The method of claim 1 , wherein the compound is contacted with the polypeptide before the succinic acid is contacted with the polypeptide.

4 . The method of claim 1 , wherein the step of determining the level of activity comprises a binding assay.

5 . The method of claim 1 , wherein the TGR18 polypeptide is recombinant.

6 . A method of treating a patient with a TGR18-associated disorder, the method comprising administering a therapeutically effective amount of a compound identified using the method of claim 1 .

7 . The method of claim 6 , wherein the TGR18-associated disorder is a renal disease.

8 . A method of identifying a modulator of a TGR164 polypeptide that has G-protein coupled receptor activity and (A) comprises at least 70% amino acid sequence identity to SEQ ID NO:18 (B) consists of at least 50 contiguous amino acids of SEQ ID NO:18, or (C) comprises the amino acid sequence of SEQ ID NO:18; wherein the method comprises:

contacting the polypeptide with: a candidate modulator compound and α-keto-glutaric acid; and

determining the level of activity of the polypeptide in comparison to the level of activity of the polypeptide in the absence of α-keto-glutaric acid.

9 . The method of claim 8 , wherein the step of determining the level of activity comprises a competitive assay.

10 . The method of claim 8 , wherein the compound is contacted with the polypeptide before the α-keto-glutaric acid is contacted with the polypeptide.

11 . The method of claim 8 , wherein the step of determining the level of activity comprises a binding assay.

12 . The method of claim 8 , wherein the TGR164 polypeptide is recombinant.

13 . A method of treating a patient with a TGR164-associated disorder, the method comprising administering a therapeutically effective amount of a compound identified using the method of claim 8 .

14 . The method of claim 13 , wherein the TGR164-associated disorder is a renal disease.